• Myriad Genetics granted 39,370 common shares to Chief Legal and Corporate Strategy officer Jennifer Lynne Fox on Nov. 1, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myriad Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001914879-26-000006), on November 02, 2026, and is solely responsible for the information contained therein.